Analysts’ upgrades for Monday, May 6th:
Bausch + Lomb (NYSE:BLCO) was upgraded by analysts at Morgan Stanley from an equal weight rating to an overweight rating. The firm currently has $18.00 price target on the stock, up from their previous price target of $16.00.
Blueprint Medicines (NASDAQ:BPMC) was upgraded by analysts at SVB Leerink LLC from an underperform rating to a market perform rating. SVB Leerink LLC currently has $97.00 target price on the stock, up from their previous target price of $50.00.
Chemomab Therapeutics (NASDAQ:CMMB) was upgraded by analysts at Oppenheimer Holdings Inc. from a market perform rating to an outperform rating. Oppenheimer Holdings Inc. currently has $6.00 price target on the stock.
Camden Property Trust (NYSE:CPT) was upgraded by analysts at Piper Sandler from an underweight rating to a neutral rating. The firm currently has $110.00 target price on the stock, up from their previous target price of $90.00.
CytomX Therapeutics (NASDAQ:CTMX) was upgraded by analysts at Jefferies Financial Group Inc. from a hold rating to a buy rating. They currently have $8.00 price target on the stock, up from their previous price target of $2.50.
Glaukos (NYSE:GKOS) was upgraded by analysts at Jefferies Financial Group Inc. from a hold rating to a buy rating. They currently have $125.00 target price on the stock, up from their previous target price of $84.00.
Mid-America Apartment Communities (NYSE:MAA) was upgraded by analysts at Wedbush from a neutral rating to an outperform rating. The firm currently has $154.00 target price on the stock, up from their previous target price of $135.00.
Melco Resorts & Entertainment (NASDAQ:MLCO) was upgraded by analysts at Morgan Stanley from an equal weight rating to an overweight rating. The firm currently has $9.60 target price on the stock, up from their previous target price of $8.30.
ModivCare (NASDAQ:MODV) was upgraded by analysts at Lake Street Capital from a hold rating to a buy rating. The firm currently has $50.00 price target on the stock.
Micron Technology (NASDAQ:MU) was upgraded by analysts at Robert W. Baird from a neutral rating to an outperform rating. They currently have $150.00 price target on the stock, up from their previous price target of $115.00.
Silicon Motion Technology (NASDAQ:SIMO) was upgraded by analysts at Morgan Stanley from an equal weight rating to an overweight rating. Morgan Stanley currently has $88.00 target price on the stock, up from their previous target price of $59.00.
Sensata Technologies (NYSE:ST) was upgraded by analysts at Evercore ISI from an in-line rating to an outperform rating. Evercore ISI currently has $60.00 price target on the stock, up from their previous price target of $44.00.
United States Steel (NYSE:X) was upgraded by analysts at Morgan Stanley from an equal weight rating to an overweight rating. The firm currently has $48.00 target price on the stock, down from their previous target price of $51.00.
Receive News & Ratings for Bausch + Lomb Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bausch + Lomb Co and related companies with MarketBeat.com's FREE daily email newsletter.